Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update and latest advances in antiretroviral therapy
Luis Menéndez‐Arias, Rafaël Delgado
Trends in Pharmacological Sciences (2021) Vol. 43, Iss. 1, pp. 16-29
Open Access | Times Cited: 139

Showing 26-50 of 139 citing articles:

Changes in the lipid profile in people with HIV after one year of antiretroviral therapy – the significance of immune parameters
Agnieszka Lembas, Andrzej Załęski, Tomasz Mikuła, et al.
IJID Regions (2025) Vol. 14, pp. 100602-100602
Open Access
Deciphering the Molecular Mechanisms of HAART‐Induced Hepatotoxicity
Devaraj Ezhilarasan, M Karthick, M. Sharmila, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 2
Closed Access
Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome
Robert Langat, Ashma Chakrawarti, Nichole R. Klatt
Current HIV/AIDS Reports (2025) Vol. 22, Iss. 1
Closed Access
Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models – a comprehensive review
Yusuf M. Idres, Adi Idris, Wenqing Gao
Drug Delivery and Translational Research (2025)
Open Access
Impact of training healthcare professionals in the detection and management of neuropsychiatric comorbidities in people with HIV: The CONECTAR project in Spain
Jordi Blanch, Estebán Martínez, Álvaro Mena, et al.
HIV Medicine (2025)
Closed Access
Twice-yearly Lenacapavir demonstrated exceptional efficacy for HIV prevention
Shujing Xu, Peng Zhan
The Innovation (2024) Vol. 5, Iss. 5, pp. 100683-100683
Open Access | Times Cited: 3
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation
Alicia Regueiro‐Ren, Sing‐Yuen Sit, Yan Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 18, pp. 11927-11948
Closed Access | Times Cited: 18
Investigation of pharmacokinetic drug interaction between clesacostat and DGAT2 inhibitor ervogastat in healthy adult participants
Aarti Sawant‐Basak, Arthur Bergman, Jessica Mancuso, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 3
Getting around the roundworms: Identifying knowledge gaps and research priorities for the ascarids
Adrian J. Wolstenholme, Erik C. Andersen, Shivani Choudhary, et al.
Advances in Parasitology/Advances in parasitology (2024), pp. 51-123
Open Access | Times Cited: 3
Targeting SARS-CoV-2 and host cell receptor interactions
Siew Pheng Lim
Antiviral Research (2022) Vol. 210, pp. 105514-105514
Open Access | Times Cited: 15
HIV-Related Atherosclerosis: State-of-the-Art-Review
Ashot Avagimyan, Nana Pogosova, L. V. Kakturskiy, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 9, pp. 101783-101783
Closed Access | Times Cited: 8
Opportunities and challenges in new HIV therapeutic discovery: what is the next step?
Shujing Xu, Lin Sun, Xinyong Liu, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 11, pp. 1195-1199
Open Access | Times Cited: 7
Longitudinal cervicovaginal microbiome and virome alterations during ART and discordant shedding in women living with HIV
Emily A. Kaelin, Caroline M. Mitchell, Jamie Soria, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
From Glycolysis to Viral Defense: The Multifaceted Impact of Glycolytic Enzymes on Human Immunodeficiency Virus Type 1 Replication
Naoki Kishimoto, Shogo Misumi
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 5, pp. 905-911
Open Access | Times Cited: 2
May I Help You with Your Coat? HIV-1 Capsid Uncoating and Reverse Transcription
Laura Arribas, Luis Menéndez‐Arias, Gilberto Betancor
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7167-7167
Open Access | Times Cited: 2
HIV-1 reverse transcriptase error rates and transcriptional thresholds based on single-strand consensus sequencing of target RNA derived from in vitro-transcription and HIV-infected cells
Javier Martínez del Río, Estrella Frutos-Beltrán, Alba Sebastián-Martín, et al.
Journal of Molecular Biology (2024) Vol. 436, Iss. 22, pp. 168815-168815
Open Access | Times Cited: 2
Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006–2020
Dandan Niu, Ticheng Xiao, Yuanyi Chen, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Transcriptome-based analysis of human peripheral blood reveals regulators of immune response in different viral infections
Sergey M. Ivanov, Olga Tarasova, Vladimir Poroikov
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Secondary metabolites of Bacillus subtilis L2 show antiviral activity against pseudorabies virus
Xiaoli Wang, Guijuan Hao, Meng Zhou, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 6
Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors
Lina Zhang, Fenju Wei, Jiwei Zhang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114760-114760
Closed Access | Times Cited: 10
Synthesis of 4′-Substituted Carbocyclic Uracil Derivatives and Their Monophosphate Prodrugs as Potential Antiviral Agents
Nicolas Biteau, Sarah Amichai, Niloufar Azadi, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 544-544
Open Access | Times Cited: 5
Discovery, Crystallographic Studies, and Mechanistic Investigations of Novel Phenylalanine Derivatives Bearing a Quinazolin-4-one Scaffold as Potent HIV Capsid Modulators
Shujing Xu, Lin Sun, Michael J. Barnett, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 23, pp. 16303-16329
Open Access | Times Cited: 5
Discovery of dual S-RBD/NRP1-targeting peptides: structure-based virtual screening, synthesis, biological evaluation, and molecular dynamics simulation studies
Chunfang Hu, Ting Guo, Yunting Zou, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 5
The Application of Prodrugs as a Tool to Enhance the Properties of Nucleoside Reverse Transcriptase Inhibitors
Lívia da Rocha Fernandes, Juliana Romano Lopes, Andressa Francielli Bonjorno, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2234-2234
Open Access | Times Cited: 5
Effects of Perceived Social Support on Health-Related Quality of Life in Asymptomatic and Symptomatic People Living with HIV in China: A Cross-Sectional Study
Meilian Xie, Aiping Wang, Kerong Wang, et al.
Current HIV Research (2023) Vol. 21, Iss. 1, pp. 63-72
Closed Access | Times Cited: 4

Scroll to top